Ignite Creation Date:
2024-05-06 @ 7:59 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06204380
Status:
RECRUITING
Last Update Posted:
2024-01-17
First Post:
2024-01-03
Brief Title:
An Observational Study on the Identification of Prescription Patterns of STAFEN Cap
Sponsor:
Hanlim Pharm Co Ltd
Organization:
Hanlim Pharm Co Ltd
Study Overview
Official Title:
An Observational Study on the Identification of Prescription Patterns of STAFEN Cap Changes in Blood Lipid Concentration and Statin-related Muscle Symptoms in Korean Patients With Mixed Dyslipidemia
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
An observational study on the identification of prescription patterns of STAFEN Cap changes in blood lipid concentration and statin-related muscle symptoms in Korean patients with mixed dyslipidemia
Detailed Description:
This study aims to observe the effectiveness of STAFEN capsule such as changes in blood lipid concentration and safety including statin-related muscle symptoms and prescription patterns under daily clinical treatment in patients who have been prescribed STAFEN capsules for the treatment of complex dyslipidemia
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None